Tocilizumab treatment with reducing and stopping methotrexate in patients with rheumatoid arthritis in stable low disease activity-state
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms T-ReX
- 22 Aug 2017 Planned number of patients changed from 65 to 51.
- 22 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 22 Dec 2016 Status changed from not yet recruiting to recruiting.